ArticleBMC cancer2020

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.

Toshiaki Akahane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.